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Abstract 
The objective of this study was to formulate sodium alginate based ophthalmic 
mucoadhesive system of gatifloxacin and its in vitro antibacterial potential on 
pathogenic microorganisms, Staphylococcus aureus and Escherichia coli. 
Sodium carboxymethylcellulose (NaCMC) was added to the formulations to 
enhance the gel bioadhesion properties. The prepared formulations were 
evaluated for their in vitro drug release, gelation behaviour, rheological 
behavior, and mucoadhesion force. All formulations in non-physiological and 
physiological condition showed pseudo plastic behavior. Increase in the 
concentration of sodium alginate and sodium CMC enhanced the muco-
adhesive force significantly. In vitro release of gatifloxacin from the system in 
simulated tear fluid (STF, pH  –  7.4), was influenced significantly by the 
properties and concentration of sodium alginate, NaCMC. Significant reduction 
in total bacterial count was observed between control and treatment groups with 
both the test organisms.  
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Introduction  
The design of an ocular dosage form which prolongs the precorneal residence time of the 
drug and enhances the corneal permeation is an exciting challenge. Ocular therapeutic 
preparations like ophthalmic solutions, suspensions and semisolids are characterised by 
several important disadvantages. Protective mechanisms including reflex blinking, solution 
drainage, lachrymation and a highly selective corneal barrier allow only 1–10% of the 
topically applied dose to be absorbed [1].  
Different kinds of approaches can be employed to increase the ocular bioavailability of the 
drug instilled, to extend the drug residence time in the cul-de-sac and to reduce the 
probability of adverse systemic effects. Incorporation of soluble polymers into an aqueous 
solution can be applied to extend the drug residence time, thereby prolonging drug 
absorption. Solutions of equal viscosity induce the same magnitude of increase in corneal 
drug absorption regardless of the chemical nature of the polymer [2], however, the 
retention of the formulation at the site of drug application can be increased not only by an 
increase in viscosity, but also by a specific interaction between the polymer and the mucin 
layer of the precorneal tear film [3].  
Mucoadhesive drug delivery systems utilize the property of bioadhesion of certain water-
soluble polymers that become adhesive to mucous membranes on hydration [4] and hence 
can be used for targeting a drug to a particular mucus tissue (e.g. gastrointestinal. buccal, 
nasal, etc.) extended period of time [5]. 
The factors influencing mucoadhesion at these sites have already been investigated as 
well [6]. When adding mucoadhesive polymers to the formulation to prolong specifically the 
precorneal residence time of ocular dosage forms, some special features, which are 
characteristic for ocular drug delivery, have to be taken into consideration. When polymer 
dispersions are applied topically as low-viscous preparations, the polymer molecules are 
fully hydrated. Therefore, the hydration state of the mucoadhesive polymer has to be 
considered in order to evaluate the effectiveness of the mucoadhesive mechanism.  
The idea of mucoadhesives is derived from the need to localize a drug at a certain site in 
the body. Often the extent of drug absorption is limited by the residence time of the drug at 
the absorption site. Particularly, in ocular drug delivery, less than 2 min are available for 
drug absorption after instillation of a drug solution into the eye, since it is removed rapidly 
by solution drainage; hence the ability to extend the contact time of a topically delivered 
drug would undoubtedly improve drug bioavailability. 
Sodium alginate, the sodium salt of alginic acid, is a natural hydrophilic polysaccharide 
containing two types of monomers, beta-D-mannuronic acid (M) and alpha-L-guluronic 
acid (G). Alginate forms 3-dimensional ionotropic hydrogel matrices, generally by the 
preferential interaction of calcium ions with the G moieties resulting in the formation of an 
inhomogeneous gel [7]. Consequently, in situ gelling occurs because of the ionic strength 
of the tear fluid, also alginate has good mucoadhesive property. Sodium CMC was 
combined in formulation to improve viscosity and for the additive effect of mucoadhesive 
property. The amount of polymers included in the formulation should be low to avoid 
irritation and ocular disturbance. So 0.1 to 0.5% w/v sodium CMC was used in this formu-
lation. In this concentration range sodium CMC formed a clear and stable formulation.   Sodium Alginate Based Mucoadhesive System for Gatifloxacin and Its In Vitro Antibacterial Activity  943 
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Sodium CMC was selected as a polymer instead of other polymers due to its better 
mucoadhesive capacity in comparison to that of other mucoadhesive polymers like poly 
(acrylic acid) (PAA), polycarbophils. PAA adhesion is very sensitive to the presence of 
ions, the shielding of the carboxyl group by cations present in the tear fluid diminish the 
interaction of PAA with the functional group on mucin [8]. Polycarbophil shows the 
maximum adhesion strength at pH-3, decreasing gradually with increasing in pH upto 5, 
above which it does not show any mucoadhesivity. 
Therefore, a combination of sodium alginate with sodium CMC would be very promising for 
ocular administration as the mucoadhesive system. The result could be a prolonging of the 
contact time. In fact, combination of alginate and HPMC for the ocular delivery of 
gatifloxacin was already studied [9]. In that study HPMC was used to decrease the amount 
of alginate in the formulation. In this study HPMC was not used as it has very low 
mucoadhesive property. 
The objective of the present work was to develop a mucoadhesive system of Gatifloxacin 
(GTN), a fluroquinolone derivative used in external infections of the eye using sodium 
alginate alone and in combination with sodium carboxymethyl cellulose, which would 
undergo gelation when instilled into the cul-de-sac of the eye and provide prolonged 
retention on the external ocular surface by a combination of gelation and mucoadhesivity 
of the formulation. 
Result and discussion  
Preparation of Formulations 
The components of the various batches of the gatifloxacin mucoadhesive system are 
shown in Table 1. Initial experiments showed that increasing the concentration of sodium 
alginate, in preparations containing only sodium alginate, beyond 2 % w/v caused gelation 
upon cooling to 40 °C (during stirring). Sodium carboxymethyl cellulose combined with 
sodium alginate in the concentration of 0.1, 0.25, and 0.5 % w/v provided the defined 
fluidity of the liquid formulation.  










1 Control 0.3  –  – 
2 GS1 0.3  0.4  – 
3 GS2 0.3  0.6  – 
4 GS3 0.3  0.6 0.1 
5 GS4 0.3  0.6  0.25 
6 GS5 0.3  0.6 0.5 
7 GS6 0.3  0.8  – 
8 GS7 0.3  1  – 
9 GS8 0.3  2  – 
Mannitol 5% was used as isotonic agent and benzalkonium chloride 0.02% 
was used as a preservative. 
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Evaluation of formulations 
The physico-chemical properties of the prepared gatifloxacin formulations are shown in 
Table 2. The drug content, clarity and pH of the formulations were found to be satisfactory 
and the formulations were liquid at both room temperature (25–28°C) and when 
refrigerated (4–8°C). The two main pre-requisites of mucoadhesive systems are viscosity 
and gelling capacity (speed and extent of gelation). The formulation should have an 
optimum viscosity that will allow easy instillation into the eye as a liquid (drops). Moreover, 
the mucoadhesive gel should preserve its integrity without dissolving or eroding for a 
prolonged period of time to facilitate sustained release of the drug to the ocular tissues. All 
the formulations showed instantaneous gelation when contacted with the gelation fluids 
(STF). However, the nature of the gel formed depended upon the polymer concentration. 
In case of gatifloxacin formulation batche GS1 showed the weakest gelation, due to the 
presence of minimal amount of sodium alginate (0.4%).  
Rheological studies 
The formulations exhibited pseudoplastic behaviour as evidenced by shear thinning and 
an increase in the shear stress with increase in the angular velocity. The administration of 
an ophthalmic formulation should not influence the pseudoplastic nature of the precorneal 
film, if they do so it should be negligible [10]. Figure 1 shows that the viscosity of the 
developed formulation in non-physiological condition (pH – 5.0). Figure 2 shows that the 
viscosity of the formulation in physiological condition (pH – 7.2). All formulations either in 
non-phsiological and physiological condition showed pseudo plastic behavior (viscosity 
that is high under the low shear rate and low under the high shear rate conditions), Which 
is fruitful for ophthalmic use due to the fact that the ocular shear rate is very high 
particularly during the blinking period [11]. The viscosity of the formulation increased with 
increasing concentrations of polymers.  
Tab. 2.  Physico-chemical properties of the prepared Gatifloxacin mucoadhesive 
systems 
Batch Code  Drug content uniformity 
(% ± S. D.) 
Gelling capacity in STF  pH 
Control    99.58 ± 1.05  − 5.1 
GS1    99.58 ± 0.25  +  5.3 
GS2    98.91 ± 0.71  ++  5.2 
GS3    99.32 ± 0.95  +++  5.3 
GS4    98.73 ± 1.03  +++  5.3 
GS5    99.51 ± 0.67  +++  5.2 
GS6    99.45 ± 0.54  +++  5.3 
GS7    98.64 ± 0.62  +++  5.4 
GS8  100.20 ± 0.55  +++  5.3 
+…Gels after few minutes; ++…Gels immediately but remains for a few hours (less stiffer);  
+++…Gelation immediate and remains for extended periods and formed gels are stiffer. 
 
Evaluation of mucoadhesivity of the formulations 
The viscosity of mucin colloidal dispersion is the net result of the resistance to flow exerted 
by individual chain segment, physical chain entanglement and the non covalent   Sodium Alginate Based Mucoadhesive System for Gatifloxacin and Its In Vitro Antibacterial Activity  945 
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intermolecular interaction such as electrostatic, hydrogen and hydrophobic bonding 
[12,  13]. These interactions are the identical forces involed in the process of mucin-
polymer adhesion [14]. Thus, force in a mucin bioadhesive system can be monitored by 
measurement of viscosity. In fact, both physical and chemical bond energies in mucin-
polymer interactions can be transformed into mechanical energy or work. This work 
causes changes in the shape or arrangement of macromolecules and is the basis for the 
viscosity changes [13]. 
The mucoadhesive forces of different formulations of gatifloxaicn mucoadhesive systems 
are shown in Table 3. The mucoadhesive force was significantly (p<0.05) increased as the 
concentration of sodium alginate and sodium CMC increased over the range of 0.4 to 2% 
and 0.1 to 0.5 %, respectively. Formulation GS8 (Containing sodium alginate concentration 
2%) exhibited maximum mucoadhesive strength. The result also showed that both sodium 
alginate and sodium CMC significantly increased the viscosity as well as the 
mucoadhesive property. 
Sodium CMC has an abundance of hydroxyl and ether groups along their length, which 
are responsible for the mucoadhesive properties. Increasing the concentration of the 
sodium CMC in the formulation increased the bonds forming groups, thus increase the 
mucoadhesicve force of the formulations [15]. Mucoadhesion behavior of alginate was due 
to the low surface tension (31.5 mN/m) of the alginate, which is lower than the critical 
surface tension of the mucin coated cornea (38 mN/m), resulting in good spreading and 
adhesion [16].  
 
Fig. 1.  Rheological behavior of mucoadhesive system of gatifloxacin in non-
physiological condition (pH – 5.0) [Values reported as mean ± SD (n = 3)] 946  K. Kesavan, G. Nath and J. K. Pandit:   
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Fig. 2.  Rheological behavior of mucoadhesive system of gatifloxacin in physiological 
condition (pH – 7.2) [Values reported as mean ± SD (n = 3)] 
 
Tab. 3.  Viscosity of formulation (ηp), component of mucoadhesion (ηb) and the force of 

















GS1  0.4  –    28.7 ± 2.61 10.2 ± 2.10   17.03 ± 2.40*
GS2  0.6  –    35.4 ± 3.20 16.3 ± 2.65  27.22 ± 2.60 
GS3  0.6  0.1    43.8 ± 2.54 28.2 ± 3.12  47.10 ± 3.20 
GS4  0.6  0.25    55.6 ± 3.41 37.5 ± 3.51   62.63 ± 3.45*
GS5  0.6  0.5    84.3 ± 2.61 52.6 ± 4.21   87.84 ± 4.25*
GS6  0.8  –    73.5 ± 4.21 43.3 ± 2.50  72.31 ± 4.61 
GS7  1  –  106.8 ± 5.61 57.7 ± 3.60  96.36 ± 3.54 
GS8  2  –  125.7 ± 4.36 63.6 ± 4.20  106.2 ± 5.70 
a Values reported as mean ± SD (n = 3); * Significantly different (p < 0.05) 
 
In vitro release 
The results clearly showed that the mucoadhesive system has the ability to retain 
gatifloxacin in its matrix network and that premature drug release will not occur.   Sodium Alginate Based Mucoadhesive System for Gatifloxacin and Its In Vitro Antibacterial Activity  947 
Sci Pharm. 2010; 78: 941–957. 
Effect of sodium alginate on drug release 
Gatifloxacin release from the control system was fast and the system were completely 
depleted of drug within 2 hr. Sodium alginate, when incorporated as a part (0.4 % to 2 % 
w/v), modulated drug release significantly (p<0.001) (Figure 3). Alginate with a high 
guluronic acid content will improve the gelling properties and reduce the total polymer to 
be introduced into the eye. Figure 3 shows that even at lower concentrations of sodium 
alginate; the drug release was sustained for an extended period. Drug release seemed to 
slow down with an increase in sodium alginate concentration. The release was significantly 
(p<0.001) slowed when the polymer concentration increased from 0.4% to 1 and 2%, while 
there was not much difference between the release patterns.  
 
Fig. 3.  Effect of sodium alginate concentration on drug release 
[Values reported as mean ± SD (n = 3); * Significantly different (p < 0.001)] 
Effect of sodium carboxy methylcellulose on drug release 
Figure 4 shows the effect of sodium carboxymethyl cellulose on GTN release. Sodium 
alginate at a concentration of 0.6% w/v was present in the formulation containing varying 
proportions of sodium carboxymethyl cellulose (GS3-GS5). The release of drug depends 
not only on the nature of the matrix, but also upon the polymer concentration. This may be 
due to structural reorganization of the hydrophilic polymer, sodium CMC. Increase in 
concentration of sodium CMC may result in increase in the gel strength of the polymer. 
When sodium CMC is exposed to an aqueous medium, it undergoes rapid hydration and 
chain relaxation to form a viscous gelatinous layer (gel layer). Comparison of the release 
profile of GS2 (containing only sodium alginate) with those of GS3-GS5 indicate that burst 
effect was considerably reduced. Sodium carboxymethyl cellulose, (incorporated at 0.1 to 
0.5% w/v) affected the drug release significantly (p < 0.001). 948  K. Kesavan, G. Nath and J. K. Pandit:   
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The initial fast release of gatifloxacin from the prepared systems could be explained by the 
fact that these systems were formulated in an aqueous vehicle. The matrix formed on 
gelation was already hydrated and hence hydration and water permeation could no longer 
limit the drug release. A similar release pattern was reported for ciprofloxacin, wherein the 
initial fast release (burst effect) decreased with an increase in polymer concentration from 
gellan and alginate systems [17]. 
By reviewing the kinetic data, it could be deduced that all the prepared formulations 
exhibited n values greater than 0.5 and less than 1 indicating an anomalous or non-Fickian 
release suggesting a coupled erosion–diffusion mechanism for the tested gatifloxacin 
mucoadhesive system. 
 
Fig. 4.   Effect of sodium CMC concentration on drug release 
[Values reported as mean ± SD (n = 3); ** Significantly different (p < 0.001)] 
Antimicrobial efficacy studies 
Determination of minimum inhibitory concentration (MIC) 
MIC determination was carried out using the serial dilution method. In GS5 formulation and 
pure drug sample the MIC concentration was found to be 0.15 and 0.075 μg/ml against 
S.aureus and E.coli, respectively. It showed that gatifloxacin retains its antimicrobial 
efficacy when formulated as mucoadhesive system. 
In vitro antibacterial activity 
Figure. 5 and 6 show in vitro antibacterial activity of free GTN and GTN mucoadhesive 
system against E. coli and S.aureus, respectively. A significant decrease in OD600 value 
was observed in comparison to control (p<0.001). In control set the OD600 value of E.coli 
and S.aureus increased with time.    Sodium Alginate Based Mucoadhesive System for Gatifloxacin and Its In Vitro Antibacterial Activity  949 
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In control set the number of viable organisms increased with time. Control group did not 
receive any antimicrobial agent. Thus under favourable condition (temperature and 
nutrient) the test organisms exhibited a significant growth. The growth of organisms were 
reduced or inhibited in presence of either in solution form or formulation which is evident 
from the growth curve. Although no significant difference was observed between the 
antimicrobial activity of the drug and formulation (p>0.001), a marginal increase of viable 
count was observed in sample tubes containing drug solution after ~4 hrs. No increase in 
the viable count was seen during the 8-h incubation with formulation. These results 
indicate the sustained release characteristics of gatifloxacin mucoadhesive system, that 
released GTN inhibits bacterial growth for a longer period. 
Interaction studies 
IR Study 
The IR spectrum of Gatifloxacin showed absorption bands for aromatic C-H (900-670 cm
−1 
several bands) alkane –CH3 (2960 cm
−1), carboxylate (3414 cm
−1), secondary amine (1550 
cm
−1), conjugated ketone (1637 cm
−1). The IR spectrum of sodium alginate exhibited 
characteristic absorption bands for hydroxyl groups (3448 cm
−1), carboxylate (1413 cm
−1) 
and primary amine (3439 cm
−1). The IR spectrum of sodium carboxymethyl cellulose 
exhibited characteristic absorption bands  for carboxylate (1419, 1597 cm
−1) and alkyl 
substituted ether (1155 cm
−1). The IR spectrum of freeze dried formulation showed 
characteristic bands of drug, i.e., there was no interaction between drug and polymers 
(Figure 7).  
DSC Study 
DSC thermograms were recorded for pure gatifloxacin, polymers and freeze dried 
formulation (Figure 8). It was observed that the characteristic endotherm (corresponding to 
melting of the drug) did not shift appreciably, suggesting lack of any interaction between 
the drug and excipients.  
Experimental  
Materials  
Gatifloxacin (GTN) was kindly gifted by Burgeon Pharmaceutical pvt. Ltd. (Kancheepuram, 
India), Sodium alginate and sodium carboxymethylcellulose were kindly gifted by 
Dr.Reddy’s laboratory (Hyderabad, India). Benzalkonium chloride was purchased from 
RFCL Ltd. (New Delhi, India). Mucin type II and Cellulose membrane were purchased from 
Sigma-Aldrich chemicals pvt. Ltd., New delhi, Mannitol was purchased from Sisco 
Research Lab. (Mumbai, India). Sodium Chloride, Sodium acetate, Calcium chloride 
(⋅2 H2O) and Glacial acetic acid were purchased from Merck (Mumbai, India). Sodium 
bicarbonate was purchased from sd fine chemical Ltd. (Mumbai, India). All other reagents 
were of analytical grade. 950  K. Kesavan, G. Nath and J. K. Pandit:   
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Fig. 5.   In vitro antibacterial activity of drug solution and formulation (GS5) against E. 
coli. 
[Values reported as mean ± SD (n = 3); * Significantly different (p < 0.001)] 
 
Fig. 6.   In vitro antibacterial activity of drug solution and formulation (GS5) against S. 
aureus. 
[Values reported as mean ± SD (n = 3); ** Significantly different (p < 0.001)]   Sodium Alginate Based Mucoadhesive System for Gatifloxacin and Its In Vitro Antibacterial Activity  951 
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Preparation of formulations 
Sodium alginate alone and in combination with sodium carboxymethyl cellulose (Table 1) 
were dissolved in hot acetate buffer pH 5.0 (70°C, prepared in fresh water for injection 
under laminar flow) by continuous stirring at 40°C. Required quantity of gatifloxacin to give 
a final drug concentration of 0.3% w/v was added to the polymeric solution and stirred until 
dissolved. Mannitol and benzalkonium chloride were added later which as isotonicity agent 
and preservative, respectively. The formulations were filled in sterile 100-ml amber 
coloured bottles, capped with rubber closures and sealed with aluminum caps. The 
formulations, in their final pack were terminally sterilized by autoclaving at 121°C and 15 
p.s.i. for 20 minutes. The sterilized formulations were stored in refrigerator (4–8°C) until 
further use. 
 
Fig. 7.   IR Spectrum solid state interaction of drug and polymers 
A – Gatifloxacin crystalline powder; B – powder obtained by freeze-drying the 
formulation (GS5) at 13.6 Pa and −46°C for 8 h; C – Sodium CMC; D – Sodium 
alginate 952  K. Kesavan, G. Nath and J. K. Pandit:   
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Fig. 8.   DSC endotherm of Gatifloxacin pure and freeze dried formulation (GS5) 
A – Gatifloxacin crystalline powder; B – powder obtained by freeze-drying the 
formulation (GS5) at 13.6 Pa and −46°C for 8 h; C – sodium alginate; D – 
Sodium CMC 
Evaluation of the formulations 
Drug content uniformity 
The bottle (n=3) containing the preparations were shaken for 2-3 minutes and 100 μl of the 
preparation was transferred aseptically to sterile 25 ml volumetric flasks with a 
micropipette and the final volume was made up with Simulated Tear Fluid (Sodium 
chloride 0.67 g, Sodium bicarbonate 0.20g, Calcium chloride (2 H2O) 0.008 g, Distilled 
water q.s. 100 ml). The concentration of GTN was determined at 287 nm (Shimadzu, UV-
1601, Japan). 
Gelation studies 
The gelation studies were carried out in gelation cells, fabricated locally using Teflon
®. The 
cells were cylindrical reservoirs capable of holding 3 ml of the gelation solution (STF). 
Within the cells located at the bottom is a 250- μl transparent plastic cup to hold the gel 
sample in place after its formation. 100 μl of the preparation was carefully placed into the 
cavity of the cup using a micropipette and 2 ml of the gelation solution was added slowly. 
Gelation was deducted by visual examination. 
Rheological studies 
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Brookfiled DV-111+ Rheometer with spindle LV-3. The viscosity of the formulations, both 
in non-physiological condition (pH – 5.0) and physiological condition (pH – 7.2) were 
determined using a 50ml aliquot of the sample. Viscosity of the samples was measured at 
different angular velocities from 10 to 100 rpm with equal wait for 3 min in each rpm. The 
angular velocity was reversed (100 to 10 rpm). The average of two readings was used to 
calculate the viscosity. 
Mucoadhesive evaluation 
A simple viscometric method was used to quantify mucin-polymer bioadhesive strength 
[18]. Viscosities of 15% (w/v) porcine gastric mucin dispersions in STF were measured 
with a Brookfield viscometer in the absence (ηm) or presence (ηt) of different formulations 
at 37°C and a shear rate of 100 rpm. Viscometric measurements were performed after 
exactly 3 min of applying the shear force to be homogeneously distributed throughout the 
sample. Viscosity components of bioadhesion (ηb) was calculated from the equation, ηt = 
ηm + ηp + ηb, where ηp is the viscosity of corresponding pure polymer solution. The force of 
bioadhesion (F) was calculated from the equation, F = ηb.σ, where σ is the rate of 
shear/sec. 
In vitro release studies 
The in-vitro release of GTN from the formulation was studied through cellulose membrane 
using a modified apparatus [19]. The freshly prepared Simulated Tear Fluid (STF) was 
used as release medium. Cellulose membrane (molecular weight cut off 12,000 D, Sigma-
Aldrich Chemicals, India), previously soaked overnight in the dissolution medium was tied 
to one end of a specifically designed glass cylinder (open at both ends). One ml of 
formulation (equivalent to 3mg of GTN) was mixed with 3ml of STF and placed into this 
assembly. The cylinder was attached to a stand and suspended in 50ml of dissolution 
medium maintained at 37±1°C and the membrane just touching the receptor medium 
surface. The dissolution medium (STF) was stirred with a star headed magnetic bead at 50 
rpm. Aliquots of 5 ml volume were withdrawn at regular intervals and replaced with an 
equal volume of pre-warmed medium. The samples were analyzed for GTN content at 287 
nm using a UV spectrophotometer (Shimadzu-1601, Japan). The in vitro release was 
studied for the control (without polymer) in order to compare the release profile with the 
mucoadhesive system of gatifloxacin.  
The release mechanism of gatifloxacin from the mucoadhesive system was investigated 
using the following equation [20] 
Qt/Qα = Kt
n 
where Qt/Q∞ is the fraction of the drug released at time t, K is a constant incorporating 
structural and geometric characteristics of the drug/polymer system, and n is the release 
exponent, which is indicative of the drug-release mechanism. When n is equal to 0.5, the 
drug is released from the polymer with Fickian diffusion mechanism. If 0.5 < n < 1, it 
indicates anomalous or non-Fickian release, whereas if n  = 1, it indicates zero-order 
release. 
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Antimicrobial efficacy studies 
Determination of minimum inhibitory concentration (MIC) 
To carry out MIC test the serial dilution method was employed [21]. Staphylococcus 
aureus (ATCC 25923) and Escherichia coli (ATCC 25922) were used as gram-positive and 
gram-negative organisms, respectively. 
The stock solution of gatifloxacin in both standard and test were prepared in the 
concentration of 3 mg/ml in acetate buffer (pH 5.0). 15 sterile test tubes were arranged in a 
rack and numbered from 1 to 15. From the stock solution serial dilutions were prepared 
using Lubria broth (LB) to give concentrations of 76.5μg/ml to 0.02μg/ml placed in 1
st tube 
to 13
th tube. One tube was considered as positive control and another tube as negative 
control. Following subcultures from frozen stock, 10μl broth of the standard S. aureus and 
E.coli  containing 1x10
6 CFU/ml strains were inoculated in all the test tubes except in 
negative control and incubated at 37°C for 24h to observe the growth. The tubes were 
observed for inhibition of growth and MIC was determined. 
In vitro antibacterial activity 
The antimicrobial sensitivity of the formulation was examined in vitro by standard 
procedure [21]. 1ml of the sample (GS5) was mixed with 100ml of STF solution for 
gelation. 1ml of the above solution was added to a set of test tubes containing cultures of 
standard E. coli and S. aureus (1x10
6 CFU/ml) in LB broth. In another set of experiment 
drug solution equivalent to 30µg was used. The test tubes were incubated at 37±0.2°C, 
with continuous shaking. At 1, 2, 3, 4, 5, 6, 7 and 8h time intervals, bacterial growth was 
determined by reading optical density at 600 nm (OD 600). Positive and negative controls 
were maintained throughout the study for comparison. The entire test was performed in 
triplicate and the values correspond to average ± S.D. 
Interaction studies 
Interaction studies were conducted by FT-IR and DSC to investigate any interaction 
between drug and excipients. 
IR Study 
The drug or polymer or powder obtained by freeze-drying the formulation (GS5) at 13.6 Pa 
and  −46°C for 8 h mixed with solid potassium bromide (KBr). The mixture was then 
pressed into a very thin pellet. The pellets were placed in the holder directly in the IR laser 
beam. Spectra were recorded using Shimadzu FTIR- 8400s loaded with IR solution 
version 1.2 software. IR spectra of drug and polymer physical mixture were compared with 
IR spectra of pure drug for any major interaction. 
DSC Study 
DSC studies of pure drug, polymer and powder obtained by freeze-drying the formulation 
(GS5) at 13.6 Pa and −46°C for 8 h were done. The samples (2.5mg) were taken in solid 
state in the pan and were compressed with a high-pressure press. DSC of the samples 
was performed using Modulated DSC systems (Q 1000 TA equipped with software Pyris 
6.0). Thermal scanning was carried out at a rate of 10°C min
−1 (from 0–300°C) and 
nitrogen purge 35 mL/min.   Sodium Alginate Based Mucoadhesive System for Gatifloxacin and Its In Vitro Antibacterial Activity  955 
Sci Pharm. 2010; 78: 941–957. 
Conclusion  
Gatifloxacin was successfully formulated as a mucoadhesive system using a combination 
of sodium alginate with sodium carboxymethyl cellulose. The formulated systems provided 
sustained release of the drug over a 12-hr period in vitro. Significant reduction in total 
bacterial count was observed between control and treatment groups with the two 
organisms, viz. S. aureus and E.coli. The developed formulation is a viable alternative to 
conventional eye drop due to its ability to enhance bioavailability through its longer 
precorneal residence time and ability to sustain release of the drug. Also important is the 
ease of administration afforded and decreased frequency of administration resulting in 
better patient compliance. 
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